Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 10, 2016 - Issue
Submit an article Journal homepage
220
Views
65
CrossRef citations to date
0
Altmetric
Original Research

Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment)

Tadakatsu Nakamura1 Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, JapanCorrespondence[email protected]
,
Tomoko Kubota1 Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan
,
Atsushi Iwakaji1 Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan
,
Masayoshi Imada1 Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan
,
Margit Kapás2 Developmental Drug Metabolism and Pharmacokinetics, Gedeon Richter Plc, Budapest, Hungary
&
Yasunori Morio1 Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan
Pages 327-338 | Published online: 14 Jan 2016

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.